Postgraduate medicine···
Guidelines for Treating Depression in Women
Updated
Abstract
Expert consensus was achieved on 76% of treatment options for depressive conditions specific to women.
- Greater consensus was observed in cases of severe depressive symptoms compared to milder symptoms.
- For severe symptoms, the first-line recommendation included antidepressant medication combined with psychotherapy.
- In less severe cases, equal endorsement was given to alternative treatments or psychotherapy over antidepressants.
- Selective serotonin reuptake inhibitors (SSRIs) were recommended as first-line treatment across all clinical situations.
- Tricyclic antidepressants were also considered strong alternatives for use during pregnancy and lactation.
Simplified
OBJECTIVES: Women constitute two-thirds of patients suffering from common depressive disorders. The treatment of depression in women is therefore a substantial public health concern. High-quality, empirical data on depressive disorders specific to women are limited. As a result, there are no comprehensive evidence-based practice guidelines on the best treatment approaches for these illnesses. We conducted a consensus survey of expert opinion on the treatment of 4 depressive conditions specific to women: premenstrual dysphoric disorder (PMDD), depression in pregnancy, postpartum depression in a mother choosing to breast-feed, and depression related to perimenopause/menopause.
METHOD: After reviewing the literature and convening a work group of leading experts, we prepared a written survey covering a total of 858 treatment options in 117 specific clinical situations. Depression severity (mild to severe) was specified for most clinical situations. Treatment options included a broad range of pharmacological, psychosocial, and alternative medicine approaches. Most options were scored using a modified version of the RAND 9-point scale for rating appropriateness of medical decisions. We identified 40 national experts, 36 (90%) of whom completed the survey. Consensus on each option was defined as a non-random distribution of scores by chi-square "goodness-of-fit" test. We assigned a categorical rank (first line/preferred choice, second line/alternate choice, third line/usually inappropriate) to each option based on the 95% confidence interval around the mean rating. Guideline tables indicating preferred treatment strategies were then developed for key clinical situations.
RESULTS: The expert panel reached consensus on 76% of the options, with greater consensus in situations involving severe symptoms. For women with severe symptoms in each of the 4 central disorder areas we asked about, the first-line recommendation was for antidepressant medication combined with other modalities (generally psychotherapy), paralleling existing guidelines for severe depression in general populations. For milder symptoms in each situation, the panel was less uniform in recommending antidepressants. For the initial treatment of milder symptoms, the panel either gave equal endorsement to other treatment modalities (e.g., nutritional or psychobehavioral approaches in PMDD; hormone replacement in perimenopause) or preferred psychotherapy over medication (in conception, pregnancy, or lactation). In all milder cases, however, antidepressants were recommended as at least second-line options. Among antidepressants, selective serotonin reuptake inhibitors (SSRIs) as a class were recommended as first-line treatment in all situations. The specific SSRIs that were preferred depended on the particular clinical situation. Tricyclic antidepressants were highly rated alternatives to SSRIs in pregnancy and lactation.
CONCLUSIONS: The experts reached a high level of consensus on the appropriateness of including both antidepressant medication, specifically SSRIs, and nonpharmacological modalities in treatment plans for severe depression in 4 key clinical situations unique to women. To evaluate many of the treatment options in this survey, the experts had to extrapolate beyond controlled data in comparing modalities with each other or in combination. Within the limits of expert opinion and with the expectation that future research data will take precedence, these guidelines provide some direction for addressing common clinical dilemmas in women. They can be used to inform clinicians and educate patients regarding the relative merits of a variety of interventions.
Related papers
Jul '05
Expert guidelines for treating depression in women
cited by 42 papers
journal article
Jan '07
Medication Treatment Guidelines for Depression in Older Adults
top 30% journal
cited by 47 papers
practice guideline
Jul '00
Expert guidelines for medication treatment of bipolar disorder (2000)
top 30% journal
cited by 87 papers
guideline
Dec '03
Guidelines for Improving Medication Treatment of Psychotic Disorders: Introduction, Methods, and Summary
cited by 112 papers
practice guideline
Mar '04
Use of Antipsychotic Medicines in Older Adults
cited by 108 papers
Jan '07
Guidelines for Treating Dementia and Its Behavioral Symptoms: Introduction, Methods, and Overview
top 30% journal
cited by 40 papers
research support, non-u.s. gov't
Aug '01
Expert Guidelines for Treating Urgent Behavioral Crises
top 30% journal
cited by 42 papers
guideline
Dec '05
Expert Guidelines for Treating Urgent Behavioral Crises (2005)
cited by 172 papers
practice guideline
Jul '05
Expert guidelines on medication treatment for depression in older adults
cited by 113 papers
journal article
Jun '05
Expert guidelines for treating sudden behavioral crises
cited by 65 papers
journal article